Your browser does not support JavaScript capabilities, which maybe required to display this page properly.


PDF FormatRequires Adobe Acrobat Reader

Table 9.6c

Immunosuppression Use for Induction by Steroid Use at Discharge, 2003 to 2007

Recipients with Liver Transplants

  No Steroids Used for Maintenance Steroids Used for Maintenance
N % N %
Functioning Graft with Immunosuppression Info at Discharge 5,944 100.0% 22,520 100.0%
Induction Drugs        
Atgam/NRATG/NRATS 100 1.7% 39 0.2%
OKT3 16 0.3% 67 0.3%
Thymoglobulin 1,220 20.5% 1,006 4.5%
Zenapax 587 9.9% 1,007 4.5%
Simulect 570 9.6% 1,267 5.6%
Campath 274 4.6% 119 0.5%
Rituximab 303 5.1% 9 0.0%
No Induction Drug Reported 3,216 54.1% 19,079 84.7%


Source: OPTN/SRTR Data as of May 1, 2008.

Includes patients with a functioning graft at discharge.

Steroids used for induction are not counted.

Individual induction drug percentages will not necessarily add up to 100 percent, as patients may be prescribed more than one induction drug.



PDF FormatRequires Adobe Acrobat Reader